Skip to main content

Advertisement

SpringerLink
Log in

Impact of codon 72 Arg > Pro single nucleotide polymorphism in TP53 gene in the risk of kangri cancer: a case control study in Kashmir

  • Research Article
  • Published:
Tumor Biology

Abstract

Kangri cancer found only in Kashmir (north India) is a unique thermally induced squamous cell carcinoma of the skin that develops because of chronic and persistent irritation due to the use of a kangri (a brazier) by the Kashmiri people to combat the chilling cold temperature during winter. Being unique to this region, the molecular etiology of the invasive kangri cancer is not known fully. The TP53 gene, codon 72 polymorphism (Arg72Pro), has been found to be associated with cancer susceptibility but has not been investigated in kangri cancer risk. A case control study was conducted to find the genotype distribution of TP53 Arg72Pro SNP and to elucidate the possible role of this SNP as risk factor in kangri cancer development. Using the polymerase chain reaction-restriction fragment length polymorphism approach, we tested the genotype distribution of 106 kangri cancer patients in comparison with 200 cancer-free controls from the same geographical region. A significant difference was observed between the control and kangri cancer patients with odds ratio = 2.02 and 95% confidence interval = 1.2–3.3 (p = 0.01). Interestingly, the proline form was abundantly observed in advanced-grade tumors (p < 0.05). We also found a significant association of the variant allele (GC + CC) with male subjects and patients >45 years of age (p < 0.05). Thus, it is evident from our study that Arg72Pro SNP is implicated in kangri cancer and that the rare, proline-related allele is connected with higher susceptibility to kangri cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Arshad AP, Zafar AS, Nighat PK, Roohi R, DilAfrozea, Adfar Y, Saleem W, Mushtaq S. Role of TP53 Arg72Pro polymorphism in urinary bladder cancer predisposition and predictive impact of proline related genotype in advanced tumors in an ethnic Kashmiri population. Cancer Genet Cytogenet. 2010;203(2):263–8.

    Article  Google Scholar 

  2. Neve EF. Kangri burn cancer. Ind Med Gaz. 1941;138–40.

  3. Maxwell T. Epitheliomas in Kashmiris. Lancet. 1879;1:152–4.

    Article  Google Scholar 

  4. Neve A. Kangri-burn epithelioma in Kashnir. Indian Med Gaz. 1900;35:81–3.

    Google Scholar 

  5. Neve EF. Kangri burn cancer. Br Med J. 1923;2:1255–6.

    Article  CAS  Google Scholar 

  6. Cross F. On a turf (peat) fire cancer: malignant changes superimposed on erythema abigni. Proc Roy Soc Med. 1967;60:53–4.

    Article  Google Scholar 

  7. Brash DE, Rudolph JA, Simon JA, Lin A, McKenna GJ, Baden HP, Halperin AJ, Ponten J. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci. 1991;88:10124–8.

    Article  CAS  Google Scholar 

  8. Tamura M, Gu J, Matsumoto K, Aota S, Parsons R, Yamada KM. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science. 1998;280:1614–7.

    Article  CAS  Google Scholar 

  9. Hussain I, ulRehman S, Afroze D, Zahoor L, Abdullah S, Hafiz A, Shah ZA, Iqbal S, Shaffi M, Das BC, Siddiqi MA. Mutational spectrum of conserved regions of TP53 and PTEN genes in Kangri cancer (of the skin) in the Kashmiri population. Mutat Res. 2009;676(1–2):5–10.

    Article  CAS  Google Scholar 

  10. Thomas M, Kalita A, Labrecque S, Pim D, Banks L, Matlashewski G. Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol. 1999;19:1092–100.

    Article  CAS  Google Scholar 

  11. Dumont P, Leu JI, Della Pietra III A, George DL, Murphy M. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet. 2003;33:357–65.

    Article  CAS  Google Scholar 

  12. Pim D, Banks L. p53 polymorphic variants at codon 72 exerts different effects on cell cycle progression. Int J Cancer. 2004;108:196–9.

    Article  CAS  Google Scholar 

  13. Wu X, Zhao H, Amos CI, Sheets S, Nakan N, Hong WK, et al. p53 genotypes and haplotypes associated with lung cancer susceptibility and ethnicity. J Natl Cancer Inst. 2002;94:681–90.

    Article  CAS  Google Scholar 

  14. Lung FW, Lee TM, Shu BC, Chang FH. P53 codon 72 polymorphism and susceptibility malignancy of colorectal cancer in Taiwan. J Cancer Res Clin Oncol. 2004;130:728e32.

    Article  Google Scholar 

  15. Katkoori VR, Jia X, Shanmugam C, Wan W, Meleth S, Bumpers H, et al. Prognostic significance of p53 codon 72 polymorphism differs with race in colorectal adenocarcinoma. Clin Cancer Res. 2009;15:2406–16.

    Article  CAS  Google Scholar 

  16. Costa S, Pinto D, Pereira D, Rodrigues H, et al. Importance of TP53 codon 72 and intron 3 duplication 16 bp polymorphisms in prediction of susceptibility on breast cancer. BMC Cancer. 2008;8:32.

    Article  Google Scholar 

  17. Shen H, Solari A, Wang X, Zhang Z, Xu Y, Wang L, et al. Lack of evidence of association of p21WAF1/CIP1 polymorphism with lung cancer susceptibility and prognosis in Taiwan. Oncol Rep. 2004;11:1115–20.

    CAS  PubMed  Google Scholar 

  18. Buyru N, Tigli H, Dalay N. Oncol Rep. 2003;10:711–4.

    CAS  PubMed  Google Scholar 

  19. Ohayon T, Gershoni-Baruch R, Papa MZ, DistelmanMenachem T, Eisenberg Barzilai S, Friedman E. The R72P P53 mutation is associated with familial breast cancer in Jewish women. Br J Cancer. 2005;92:1144–8.

    Article  CAS  Google Scholar 

  20. Kawaguchi H, Ohno S, Araki K, Miyazaki M, Saeki H, Watanabe M, et al. p53 polymorphism in human papillomavirus-associated esophageal cancer. Cancer Res. 2000;60:2753–5.

    CAS  PubMed  Google Scholar 

  21. Dokianakis DN, Koumantaki E, Billiri K, Spandidos DA. Int J P53 codon 72 polymorphism as a risk facor in the development of HPV-associated non-melanoma skin cancers in immunocompetenthost. Mol Med. 2000;5:405–9.

    CAS  Google Scholar 

  22. De Oliveira WR, Rady PL, Grady J, Hughes TK, Neto CF, Rivitti EA, et al. Association of p53 arginine polymorphism with skin cancer. Int J Dermatol. 2004;43:489–93.

    Article  Google Scholar 

  23. Wu X, Zhao H, Amos CI, Shete S, Makan N, Hong WK, et al. p53 genotypes and haplotypes associated with lung cancer susceptibility and ethnicity. J Natl Cancer Inst. 2002;94:681–90.

    Article  CAS  Google Scholar 

  24. Soulitzis N, Sourvinos G, Dokianakis DN, Spandidos DA. p53 polymorphism at codon 72 is a known risk marker for various malignancies, but it has not been studied in hypopharyngeal cancer. Cancer Lett. 2002;179:175–83.

    Article  CAS  Google Scholar 

  25. Granja F, Morari J, Morari EC, Correa LA, Assumpcao LV, Ward LS. GST profiling may be useful in the screening for thyroid nodule malignancy. Cancer Lett. 2004;210:151–7.

    Article  CAS  Google Scholar 

  26. Tsai MH, Lin CD, Hsieh YY, Chang FC, Tsai FJ, Chen WC, et al. Prognostic significance of the proline form of p53 codon 72 polymorphism in nasopharyngeal carcinoma. Laryngoscope. 2002;112:116–9.

    Article  CAS  Google Scholar 

  27. Tiwawech D, Srivatanakul P, Karaluk A, Ishida T. Cytochrome P450 2A6 polymorphism in nasopharyngeal carcinoma. Cancer Lett. 2003;198:69–75.

    Article  CAS  Google Scholar 

  28. Chen YC, Xu L, Guo YL, Su HJ, Hsueh YM, Smith TJ, et al. Genetic polymorphism in p53 codon 72 and skin cancer in southwesternTaiwan. J Environ Sci Health, Part A: Tox Hazard Subst Environ Eng. 2003;38:201–11.

    Article  Google Scholar 

  29. Kuroda Y, Tsukino H, Nakao H, Imai H, Katoh T. p53 codon 72 polymorphism and urothelial cancer risk. Cancer Lett. 2003;189:77–83.

    Article  CAS  Google Scholar 

  30. Zhang JH, Li Y, Wang R, Wen DG, Wu ML, He M. Association of cyclin D1 (G870A) polymorphism with susceptibility to esophageal and gastric cardiac carcinoma in a northern Chinese population. Int J Cancer. 2003;105(2):281–4.

    Article  CAS  Google Scholar 

  31. Omori S, Yoshida S, Kennedy SH, Negoro K, Hamana S, Barlow DH, Maruo T. Polymorphism at codon 72 of the p53 gene is not associated with endometriosis in a Japanese population. J Soc Gynecol Investig. 2004;11:2320–6.

    Article  Google Scholar 

  32. Beckman G, Birgander R, Sjalander A, et al. Is p53 polymorphism maintained by natural selection? Hum Hered. 1994;44:266–70.

    Article  CAS  Google Scholar 

  33. Chen WC, Tsai FJ, Wu JJ, Wu HC, Lu HF, Li CW. Distribution of p53 codon 72 polymorphism in bladder cancer-proline form is prominent in invasive tumor. Urol Res. 2002;28:293–6.

    Article  CAS  Google Scholar 

  34. Kressner U, Inganas M, Byding S, Ingrid B, Lars P, Bengt G, et al. Prognostic value of p53 genetic changes in colorectal cancer. J Clin Oncol. 1999;17:593–9.

    Article  CAS  Google Scholar 

  35. Mani S, Rajaraman S, Ranganathan R, Veluswami S, Karunakaran N, Thanagrajan R. Role of GSTM1, GSTP1(II105Val) and p53 (Arg72-Pro) genetic polymorphisms and the risk of breast cancer—a case control study from South India. Asian Pac J Cancer Prev. 2007;8:253–7.

    Google Scholar 

  36. Yao-Yuan H, Chich-Sheng L. P53 codon 11, 72 and 248 gene polymorphisms in endometriosis. Int J Biol Sci. 2006;2:188–93.

    Google Scholar 

  37. Sjalander A, Birgander R, Athlin L, Stenling R, Rutegard J, Beckman L, et al. P53 germ line haplotypes associated with increased risk for colorectal cancer. Carcinogenesis. 1995;16:1461–4.

    Article  CAS  Google Scholar 

  38. Marin MC, Jost CA, Brooks LA, Irwin MS, et al. A common polymorphism acts as an intragenic modifier of mutant p53 behaviour. Nat Genet. 2000;25:47–54.

    Article  CAS  Google Scholar 

  39. Agorastos T, Lambropoulos AF, Constantinidis TC, Kotsis A, Bontis JN. p53 codon 72 polymorphism and risk of intra-epithelial and invasive cervical neoplasia in Greek women. Eur J Cancer Prev. 2000;9:113–8.

    Article  CAS  Google Scholar 

  40. Nagpal JK, Sahni S, Das BR. P53 codon 72 polymorphism and susceptibility to development of human papilloma virus-associated cervical cancer in Indian women. Eur J Clin Investig. 2002;32:943–8.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Immunology and Molecular Medicine, Sher-I-Kashmir Institute of Medical Sciences, Soura, Srinagar, Kashmir, India, 190011

    Arshad A. Pandith, Nargis Rashid, Niyaz Azad & Mushtaq A. Siddiqi

  2. Department of Cl. Biochemistry, Sher-I-Kashmir Institute of Medical Sciences, Soura, Srinagar, Kashmir, India

    Nighat P. Khan

  3. Department of Plastic Surgery, Sher-I-Kashmir Institute of Medical Sciences, Soura, Srinagar, Kashmir, India

    Inam Zaroo & Adil Hafiz

Authors
  1. Arshad A. Pandith
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nighat P. Khan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nargis Rashid
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Niyaz Azad
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Inam Zaroo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Adil Hafiz
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mushtaq A. Siddiqi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mushtaq A. Siddiqi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pandith, A.A., Khan, N.P., Rashid, N. et al. Impact of codon 72 Arg > Pro single nucleotide polymorphism in TP53 gene in the risk of kangri cancer: a case control study in Kashmir. Tumor Biol. 33, 927–933 (2012). https://doi.org/10.1007/s13277-012-0318-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-012-0318-2

Keywords

Search

Navigation